Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.650
+0.100 (6.45%)
At close: Oct 27, 2025, 4:00 PM EDT
1.660
+0.010 (0.61%)
After-hours: Oct 27, 2025, 5:42 PM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $89.49 million as of October 27, 2025. Its market cap has increased by 18.70% in one year.
Market Cap
89.49M
Enterprise Value
304.94M
1-Year Change
18.70%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $299.25M to $89.49M, a decrease of -70.09%. That is a compound annual growth rate of -13.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 81.44M | 10.73% |
| Dec 31, 2024 | 73.55M | -80.23% |
| Dec 29, 2023 | 372.10M | 5,065.15% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.02M | -47.56% |
| Dec 31, 2020 | 156.41M | -32.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.98B |
| Johnson & Johnson | 456.13B |
| AbbVie | 402.76B |
| UnitedHealth Group | 329.34B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 218.74B |